A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD

Clinical trial NCT04812262 · COMPLETED

Trial details

NCT number: NCT04812262
Sponsor: Neuraly, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity Type2 Diabetes NAFLD

Start date: 2021-02-24
Primary completion: 2022-12-20
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.